Dupilumab

Source:
British Association of Dermatologists - BAD
Publication date:
12 June 2019

Abstract

Dupilumab is a biologic medicine that has been designed to treat eczema. It works by reducing inflammation. It works on chemical messengers (known as a ‘cytokines’) in the body called ‘interleukin-4’ (IL-4) and ‘interleukin-13’ (IL-13).